Pulse Biosciences CEO Purchases 15,000 Shares in Open-Market Transaction
On May 11, 2026, Pulse Biosciences CEO Paul A. LaViolette purchased 15,000 shares of company stock at $19.69 per share for a total value of $295,350. This transaction increased his direct ownership stake from 846 to 15,846 shares and marked the CEO's first open-market purchase in recent filing history.
Tickers: $PLSE
Topics: CEO ownership open-market transaction stock purchase